In this video, Celosia Therapeutics co-founders Professor Lars Ittner and Professor Yazi Ke speak about the scientific discovery of CTx1000, Celosia’s lead asset, and its clinical pipeline.
Professor Lars Ittner is co-founder and Chief Medical Officer of Celosia Therapeutics. He is also the Director of the Dementia Research Centre at Macquarie University.
Professor Yazi Ke is co-founder and Chief Operating Officer of Celosia Therapeutics. She is also the Deputy Director of the Dementia Research Centre at Macquarie University.
Topics in this video include:
00:00 – Introduction to Prof Ittner and Prof Ke
01:26 – Prof Ittner and Prof Ke’s roles and responsibitlities within Celosia Therapeutics
02:17 – Key assets under Celosia Therapeutics
02:50 – Science behind Celosia Therapeutics and how the discovery came about
08:12 – Next steps for CTx1000